Wikidata

(Q62811120)

English

Study of Melflufen + Dex With Bortezomib or Daratumumab in Patients With RRMM

clinical trial

In more languages

Statements

short name
ANCHOR (English)
0 references
title
An Open-Label Phase 1/2a Study of the Safety and Efficacy of Melflufen and Dexamethasone in Combination With Either Bortezomib or Daratumumab in Patients With Relapsed or Relapsed-Refractory Multiple Myeloma (English)
0 references
country
France
0 references
Spain
0 references
start time
16 April 2018
0 references
end time
31 December 2019
0 references
number of participants
80
0 references
research intervention
(RS)-cyclophosphamide
0 references
dexamethasone acetate
0 references
bortezomib
0 references
daratumumab
0 references
melphalan
0 references
minimum age
18 year
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q62811120&oldid=2035754097"